We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTB
12126
PUT
RTB Digital
RTB
$237M
$30K ﹤0.01%
81
-39
-33% -$37.6K
SPRO icon
12127
CALL
Spero Therapeutics
SPRO
$71.6M
$30K ﹤0.01%
40,800
+24,000
+143% +$69.8K
UAMY icon
12128
CALL
United States Antimony
UAMY
$825M
$30K ﹤0.01%
75,000
+19,300
+35% +$8.38K
ALPP
12129
CALL
DELISTED
Alpine 4 Holdings Inc
ALPP
$30K ﹤0.01%
5,225
-1,450
-22% -$9.3K
BHIL
12130
PUT
DELISTED
Benson Hill, Inc.
BHIL
$30K ﹤0.01%
314
-95
-23% -$11.2K
BETS
12131
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
$30K ﹤0.01%
+7
New +$35.3K
SURF
12132
PUT
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$30K ﹤0.01%
18,400
-17,400
-49% -$36.1K
ELOX
12133
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$30K ﹤0.01%
+2,794
New +$38.6K
TUEM
12134
DELISTED
Tuesday Morning Corp
TUEM
$30K ﹤0.01%
+2,754
New +$56.4K
EPWR.WS
12135
DELISTED
Empowerment & Inclusion Capital I Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
EPWR.WS
$30K ﹤0.01%
369,481
-616,657
-63% -$81.6K
MILE
12136
CALL
DELISTED
Metromile, Inc. Common Stock
MILE
$30K ﹤0.01%
32,600
-3,500
-10% -$3.57K
SPI
12137
PUT
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$30K ﹤0.01%
17,100
ARDX icon
12138
PUT
Ardelyx
ARDX
$1.05B
$29K ﹤0.01%
48,700
-32,800
-40% -$24.2K
BLRX
12139
BioLineRX
BLRX
$12M
$29K ﹤0.01%
+569
New +$31.6K
MBAI
12140
Check-Cap
MBAI
$11.8M
$29K ﹤0.01%
668
-758
-53% -$37.8K
DAVE icon
12141
CALL
Dave Inc
DAVE
$4.27B
$29K ﹤0.01%
1,328
-1,338
-50% -$130K
PED icon
12142
PEDEVCO
PED
$166M
$29K ﹤0.01%
1,248
+26
+2% +$666
PLSE icon
12143
CALL
Pulse Biosciences
PLSE
$3.18B
$29K ﹤0.01%
+18,900
New +$47.5K
SCYX icon
12144
SCYNEXIS
SCYX
$51.5M
$29K ﹤0.01%
1,947
-2,270
-54% -$43.7K
SLE icon
12145
Super League Enterprise
SLE
$3.65M
$29K ﹤0.01%
3
-2
-40% -$26K
VRCA icon
12146
CALL
Verrica Pharmaceuticals
VRCA
$85.4M
$29K ﹤0.01%
+1,500
New +$75.4K
XHG
12147
XChange TEC
XHG
$196M
$29K ﹤0.01%
+1
New +$18.6K
CMRX
12148
PUT
DELISTED
Chimerix, Inc.
CMRX
$29K ﹤0.01%
13,700
-20,800
-60% -$66.8K
BYNOW
12149
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$29K ﹤0.01%
+279,595
New +$46.9K
PFIE
12150
DELISTED
Profire Energy, Inc
PFIE
$29K ﹤0.01%
+20,257
New +$27.2K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.